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The mechanism by which folate deficiency influences
carcinogenesis is not well established, but a phenotype
of DNA strand breaks, mutations, and chromosomal in-
stability suggests an inability to repair DNA damage. To
elucidate the mechanism by which folate deficiency in-
fluences carcinogenicity, we have analyzed the effect of
folate deficiency on base excision repair (BER), the
pathway responsible for repairing uracil in DNA. We
observe an up-regulation in initiation of BER in liver of
the folate-deficient mice, as evidenced by an increase in
uracil DNA glycosylase protein (30%, p < 0.01) and ac-
tivity (31%, p < 0.05). However, no up-regulation in ei-
ther BER or its rate-determining enzyme, DNA polym-
erase  (-pol) is observed in response to folate
deficiency. Accordingly, an accumulation of repair in-
termediates in the form of DNA single strand breaks
(37% increase, p < 0.03) is observed. These data indicate
that folate deficiency alters the balance and coordina-
tion of BER by stimulating initiation without subse-
quently stimulating the completion of repair, resulting
in a functional BER deficiency. In directly establishing
that the inability to induce -pol and mount a BER re-
sponse when folate is deficient is causative in the accu-
mulation of toxic repair intermediates, -pol-haploin-
sufficient mice subjected to folate deficiency displayed
additional increases in DNA single strand breaks (52%
increase, p < 0.05) as well as accumulation in aldehydic
DNA lesions (38% increase, p < 0.01). Since young -pol-
haploinsufficient mice do not spontaneously exhibit in-
creased levels of these repair intermediates, these data
demonstrate that folate deficiency and -pol haploinsuf-
ficiency interact to increase the accumulation of DNA
damage. In addition to establishing a direct role for
-pol in the phenotype expressed by folate deficiency,
these data are also consistent with the concept that
repair of uracil and abasic sites is more efficient than
repair of oxidized bases.
In human studies, folate deficiency is associated with can-
cers of the lung, cervix, brain, esophagus, pancreas, breast,
colon, and liver (reviewed in Refs. 1 and 2). In support of the
epidemiology, the role of folate in the development of both colon
and liver cancer has been experimentally demonstrated in an-
imal studies. Folate deficiency enhances the carcinogenic effect
of dimethylhydrazine (3), whereas folate supplementation is
protective (4). Folate/methyl deficiency results in hepatocarci-
nogenesis (5). Additionally, livers of folate/methyl-deficient
rats accumulate preneoplastic changes in response to folate
deficiency (6). It is suggested that the carcinogenic properties of
folate deficiency are related to a reduction in S-adenosylmethi-
onine levels altering DNA methylation status and/or to deple-
tion of thymidylate resulting in increased uracil content of
DNA. Additionally, folate is required for de novo purine biosyn-
thesis. Which of these factors may be responsible for inducing
carcinogenesis is presently unknown.
Whereas the underlying mechanism connecting folate defi-
ciency to cancer remains unknown, it is clear that folate defi-
ciency induces a phenotype suggestive of an inability to repair
DNA damage. The accumulation of strand breaks, mutations,
and chromosomal instability observed in response to folate
deficiency all suggest that DNA repair capacity is inhibited. In
support of this, folate-deficient cells and animals inefficiently
repair alkylation damage (7). Folate deficiency acts synergisti-
cally with ethane methyl sulfonate in Chinese hamster ovary
cells (8), suggesting an inability to repair ethane methyl sul-
fonate-induced damage. Folate depletion in human lympho-
cytes sensitizes to oxidative damage induced by hydrogen per-
oxide (9). Human colon epithelial cells grown in folate-deficient
medium are unable to repair damages induced by methylmeth-
ane sulfonate and hydrogen peroxide (10). Folate deficiency
impairs the ability of neurons and colonocytes to repair DNA
damage (11, 12). These data suggest that the pathway respon-
sible for repairing these damages may be ineffective when
folate is limiting by demonstrating a persistence of DNA dam-
age but stop short of directly measuring DNA repair capacity.
The objectives of this study are to directly measure the effects
of folate deficiency on DNA repair capacity and to begin iden-
tifying the molecular mechanisms responsible for precipitating
a phenotype of cancer susceptibility when folate is deficient.
Uracil has been shown to accumulate in response to folate
deficiency (9, 10, 13–15). The DNA repair pathway for removal
of uracil is the base excision repair (BER)1 pathway. The BER
pathway repairs small, non-helix-distorting lesions in the
DNA. In the process of repairing uracil, the following sequence
of events occurs. Uracil-DNA glycosylase (UDG), a monofunc-
* This work was supported by National Institutes of Health Grant
1R21-DK62256 (to A. R. H.) and a grant from the American Institute for
Cancer Research (to A. R. H.). The costs of publication of this article
were defrayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence and reprint requests should be addressed:
Dept. of Nutrition & Food Science, 3009 Science Hall, Wayne State
University, Detroit, MI 48202. Tel.: 313-577-2753; Fax: 313-577-8616;
E-mail: ahmad.heydari@wayne.edu.
1 The abbreviations used are: BER, base excision repair; UDG, uracil-
DNA glycosylase; Ape, AP endonuclease; -pol, polymerase ; ASB, alde-
hyde-reactive probe slot blot; ADL, aldehydic DNA lesion; DTT, dithio-
threitol; I.D.V., integrated density value; ROPS, random oligonucleotide-
primed synthesis; TEMPO, 2,2,6,6-tetramethylpiperidin-oxyl.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 279, No. 35, Issue of August 27, pp. 36504–36513, 2004
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org36504
This is an Open Access article under the CC BY license.
tional glycosylase, excises uracil from the DNA backbone, cre-
ating a transient abasic site. AP endonuclease 1 (Ape1) cleaves
the DNA backbone to allow for incorporation of a correct nu-
cleotide by DNA polymerase  (-pol). This step results in the
transient formation of both a 3-OH-containing DNA single
strand break and a deoxyribose phosphate flap containing an
aldehydic group. -pol also performs the rate-limiting step of
deoxyribose flap excision (16), at which point only the 3-OH
group remains until ligation occurs (ligase 1 or ligase 3-XRCC1
complex), at which point the strand break is fully resolved.
Typically, BER functions as a tightly coordinated sequence of
enzymatic events such that damage is removed, repair is com-
pleted, and intermediate products generated during repair do
not accumulate. Mice with gene-targeted disruptions in the
rate-limiting step of BER exhibit a dysregulation in this coor-
dination and accumulate DNA single strand breaks both spon-
taneously and in response to carcinogen exposure, have a re-
duced DNA damage threshold, and exhibit genomic instability
in the forms of both mutation induction and chromosomal
damage (17). The phenotype of folate deficiency includes accu-
mulation of strand breaks (9, 10, 15, 18, 19), reduced tolerance
to DNA-damaging agents, increased mutation induction (7, 8,
20), and chromosomal instability (21, 22) (i.e. folate deficiency
induces a phenotype identical to BER deficiency).
The objective of this study was to directly determine the
effect of folate deficiency on base excision repair capacity. Be-
cause BER is DNA damage-inducible (23, 24), we expected to
observe an induction in the activity of this repair pathway in
response to the DNA damage induced by folate deficiency.
However, in response to folate deficiency we fail to observe an
up-regulation in either BER or the rate-determining enzyme in
the pathway, -pol. This lack of response by the BER pathway
should result in an accumulation of the DNA damage induced
by folate deficiency. We provide evidence that the initial step of
BER, glycosylase-initiated removal of uracil, is up-regulated in
response to folate deficiency, without a coordinating increase in
activity of the subsequent steps of repair. This dysregulation of
BER induces a state of BER deficiency mimicking that ob-
served in mice heterozygous for -pol. Our data demonstrate
that in response to folate deficiency repair is initiated but not
completed, resulting in an accumulation of DNA repair inter-
mediate products that are genotoxic (25). Since BER deficiency
increases cancer susceptibility, this functional BER deficiency
in response to folate deficiency may provide an important
mechanistic explanation for the increased cancer risk associ-
ated with folate deficiency. As such, human polymorphisms
and functional mutations within the -pol gene may interact
with folate deficiency to increase cancer risk. This hypothesis is
supported by our data demonstrating that folate deficiency




Experiments were performed in young (3–4 months) male C57BL/6-
specific pathogen-free mice in accordance with the National Institutes
of Health guidelines for the use and care of laboratory animals. The
Wayne State University Animal Investigation Committee approved the
animal protocol. Mice were maintained on a 12-h light/dark cycle and
fed standard mouse chow and water ad libitum. Mice heterozygous for
the DNA polymerase  gene (-pol/) were created in Rajewsky’s
laboratory by deletion of the promoter and the first exon of the -pol
gene (26). The animals appear to be normal and are fertile; there is no
retardation in food intake, weight gain, or growth rate. The genotype of
the mice was determined as described previously (17).
At 3–4 months of age, 20 -pol/ and 20 -pol/ mice were ran-
domly assigned to two dietary groups and were fed AIN93G-purified
isoenergetic diets. (Dyets, Inc., Lehigh Valley, PA). The control group
received a folate adequate diet containing 2 mg/kg folic acid. The ex-
perimental group received a folate-deficient diet containing 0 mg/kg folic
acid. Diets were stored at 20 °C. 1% succinyl sulfathiazole was added to
all diets. The animals’ food intake and body weights were monitored twice
weekly to monitor for signs of toxicity (i.e. weight loss), and the experi-
mental diets were continued for 8 weeks. Animals were anesthetized
under CO2 and sacrificed by cervical dislocation. Whole blood was col-
lected, and tissues were flash frozen and stored in liquid nitrogen.
Folate Assay
Serum folate levels were measured using the SimulTRAC-SNB ra-
dioassay kit for vitamin B12 (
57Co) and folate (125I) per the manufactur-
er’s protocol (ICN Diagnostics, Orangeburg, NY). Blood was collected at
time of sacrifice and allowed to clot at room temperature for 60 min.
Samples were centrifuged, and serum was collected for immediate
analysis of serum folate levels. Standards provided in the kit were used
to generate a standard curve for determination of sample folate values.
Radioactivity was measured by a -counter, and values were calculated
as described by the manufacturer for both serum folate and serum B12.
Isolation of DNA
TEMPO Extraction of DNA—Liver DNA for the aldehyde-reactive
probe slot blot (ASB) assay was extracted according to the method
described by Hofer and Moller (27) with some modifications. This
method minimizes artifactual DNA damage by using 20 mM TEMPO in
all solutions and reagents and by minimizing heat treatment of DNA.
Briefly, 100 mg of liver tissue was homogenized in 5 ml of ice-cold
phosphate-buffered saline with 20 mM TEMPO and centrifuged at
2000  g at 4 °C for 5 min. Supernatant was decanted, and pellet was
resuspended in 2.5 ml of lysis buffer (pH 8.0; Applied Biosystems,
Foster City, CA) with 20 mM TEMPO. Proteinase K (30 units; Ambion,
Austin, TX) was added, and samples were incubated overnight at 4 °C.
DNA was extracted with 2.5 ml 70% phenol/water/chloroform (Applied
Biosystems, Foster City, CA) with 20 mM TEMPO. Further extraction
with 2.5 ml of sevag (chloroform/isoamyl alcohol, 24:1) with 20 mM
TEMPO was completed. DNA was precipitated using 7.5% 4 M NaCl and
2 volumes of 100% cold ethanol, and pellet was washed in 70% ethanol.
The pellet was resuspended in 700 l of phosphate-buffered saline with
20 mM TEMPO and rehydrated at 4 °C. The samples were then treated
with RNase A (2 g) and RNase T1 (1,000 units; Ambion, Austin, TX) at
37 °C for 30 min to digest the RNA contamination. DNA was cold
ethanol-precipitated and resuspended in 400 l of deionized water at
4 °C. DNA was stored at 70 °C.
Gravity Tip Column Extraction of DNA—DNA for the random oligo-
nucleotide-primed synthesis (ROPS) assay was isolated using Qiagen
(Valencia, CA) gravity tip columns as described in the manufacturer’s
protocol. This method generates large fragments of DNA (up to 150 kb)
while minimizing shearing.
ASB Assay
Detection of aldehydic DNA lesions (ADLs) was carried out by ASB
as described previously (28) with slight modifications. DNA (8 g) was
incubated in 30 l of phosphate-buffered saline with 2 mM aldehyde
reactive probe (Dojindo Laboratories, Kumamoto, Japan) at 37 °C for 10
min. DNA was precipitated by the cold ethanol method (described
above) and resuspended in 1 TE buffer overnight at 4 °C. DNA was
heat-denatured at 100 °C for 10 min, quickly chilled on ice, and mixed
with an equal volume of 2 M ammonium acetate. The nitrocellulose
membrane (Schleicher & Schuell) was prewet in deionized water and
washed for 10 min in 1 mM ammonium acetate. DNA was immobilized
on the pretreated nitrocellulose membrane using an Invitrogen filtra-
tion manifold system. The membrane was washed in 5 SSC for 15 min
at 37 °C and then baked under vacuum at 80 °C for 30 min. The dried
membrane was incubated in a hybridization buffer (20 mM Tris, pH 7.5,
0.1 M NaCl, 1 mM EDTA, 0.5% (w/v) casein, 0.25% (w/v) bovine serum
albumin, 0.1% (v/v) Tween 20) for 30 min at room temperature. The
membrane was then incubated in fresh hybridization buffer containing
100 l of streptavidin-conjugated horseradish peroxidase (BioGenex,
San Ramon, CA) at room temperature for 45 min. Following incubation
in horseradish peroxidase, the membrane was washed three times for 5
min each at 37 °C in TBS, pH 7.5 (0.26 M NaCl, 1 mM EDTA, 20 mM Tris,
pH 7.5, 0.1% Tween 20). Membrane was incubated in ECL (Pierce) for
5 min at room temperature and visualized using a ChemiImager™
system (AlphaInnotech, San Leandro, CA).
Isolation of Crude Nuclear Extract
Nuclear proteins for Western analyses and enzymatic activity assays
were isolated using the Sigma CelLytic™ NuCLEAR™ extraction kit, a
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method that disrupts cells with hypotonic buffer, allowing the cytoplas-
mic fraction to be removed while the nuclear proteins are released from
the nuclei by a high salt buffer. All samples and tubes were handled and
chilled on ice, and all solutions were made fresh according to the
manufacturer’s protocol. The extract was snap frozen in liquid nitrogen
and stored at 70 °C. In order to remove salt, the crude nuclear extract
was dialyzed against 1 liter of dialysis buffer (20 mM Tris-HCl, pH 8.0,
100 mM KCl, 10 mM NaS2O5, 0.1 mM DTT, 0.1 mM phenylmethylsulfonyl
fluoride, 1 g/ml pepstatin A) for 4–6 h at 4 °C using Slide-A-Lyzer®
mini-dialysis units suspended in a floatation device (Pierce). The dia-
lyzed nuclear extracts were flash frozen in liquid nitrogen and stored at
70 °C. Protein concentrations of the nuclear extracts were determined
according to Bradford using Protein Assay Kit I (Bio-Rad).
Western Blot Analyses
Western analysis was performed using liver nuclear extracts (50 g)
subjected to 10% SDS-PAGE and transferred to a Hybond™ ECL™
nitrocellulose membrane (Amersham Biosciences) using a Bio-Rad
semidry transfer apparatus. Prior to hybridization, the membranes
were stained with MemCode (Pierce) to ensure equal transfer of protein
to the membrane. Western blot analysis was accomplished using man-
ufacturer-recommended dilutions of antisera developed against UDG
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA), p53 (polyclonal an-
tibody 240; Santa Cruz Biotechnology), -pol (Ab-1 Clone 18S; NeoMar-
kers, Fremont, CA), and Ape/Ref1 (Novus Biologicals, Littleton, CO).
The bands were detected and quantified using a ChemiImager™ sys-
tem (AlphaInnotech) after incubation in SuperSignal® West Pico
chemiluminescent substrate (Pierce). The data are expressed as the
integrated density value (I.D.V.) of the band per g of protein loaded.
UDG Activity Assay
UDG activity was determined as described by Stuart et al. (29).
Briefly, the 20-l reaction contained 70 mM Hepes (pH 7.5), 1 mM
EDTA, 1 mM DTT, 75 mM NaCl, 0.5% bovine serum albumin, 90 fmol of
5-end-labeled single-stranded uracil-containing oligonucleotide that
was 3-protected by an amino-spacer (5-ATATACCGCGGUCGGC-
CGATCAAGCTTATT-3, MIDLAND, Midland, TX), and 5 g of liver
nuclear extract. Reactions were incubated at 37 °C for 1 h and then
terminated by the addition of 5 g of proteinase K and 1 l of 10% SDS
and incubation at 55 °C for 30 min. DNA was precipitated in glycogen,
ammonium acetate, and ethanol at 20 °C overnight, resuspended in a
loading buffer containing 80% formamide, 10 mM EDTA, and 1 g/ml
each of bromphenol blue and xylene cyanol FF. Substrate and reaction
products were separated on a 20% denaturing sequencing gel. Glycosy-
lase activity (presence of an 11-mer band) was visualized and quantified
using a Molecular Imager® System (Bio-Rad) by calculating the relative
amount of the 11-mer oligonucleotide product with the unreacted 30-
mer substrate (product/product  substrate). The data are expressed as
machine counts/g of protein. Negative controls consisted of the reac-
tion mixture and oligonucleotide in the absence of nuclear extract. 1
unit of uracil DNA glycosylase inhibitor was added to one sample in
each reaction to demonstrate that incision activity was the result of
UDG specifically and not another uracil-specific glycosylase (i.e.
SMUG).
Ape Activity Assay
The 5-endonuclease activity of Ape was analyzed using a quantita-
tive in vitro assay that measures the incision of a 26-mer duplex
oligonucleotide substrate containing a tetrahydrofuran (F) AP site as
previously described (30). A 26-mer oligonucleotide (5-AATTCACCG-
GTACCFTCTAGAATTCG-3) was 5-end-labeled and annealed to an
equimolar amount of the complementary strand (5-CGAATTCTA-
GAGGGTACCGGTGAATT-3). 2.5 pmol of double strand oligonucleo-
tide was incubated with 100 ng of crude nuclear extract from liver of
control and folate-deficient mice for 15 min at 37 °C and stopped by the
addition of 50 mM EDTA (reaction mixture; final concentrations: 50 mM
Hepes, pH 7.5, 50 mM KCl, 10 mM MgCl2, 2 mM DTT, 1 g/ml bovine
serum albumin, and 0.05% Triton X-100). Reaction products were run
FIG. 1. Effect of dietary folate on
body weight and plasma folate sta-
tus. A, weight of animals before and after
the implementation of the folate-deficient
and -adequate diet. Young (3–4 months)
male C57BL/6 mice were fed AIN93G pu-
rified isoenergetic diets containing either
2 mg/kg folic acid (folate-adequate) or 0
mg/kg folic acid (folate-deficient) as de-
scribed under “Experimental Proce-
dures.” The experimental diets were con-
tinued for 8 weeks, and the animals’ food
intake and body weights were measured
twice weekly. The animals’ weights in
grams are expressed as the means  S.E.
for data obtained from 10 mice in each
group. B, serum folate levels in mice fed
folate-adequate or folate-deficient diets
were measured using the SimulTRAC-
SNB radioassay kit per the manufactur-
er’s protocol (ICN Diagnostics, Orange-
burg, NY). The relative level of folate in
plasma is expressed as ng/ml of plasma
based on standards provided in the kit,
and the data are expressed as the
means  S.E. for data obtained from 10
mice in each group. Filled bar, 2 mg/kg
folic acid; open bar, 0 mg/kg folic acid.
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on a 15% denaturing sequencing gel. Endonuclease activity (presence of
a 14-mer band) was visualized and quantified using a Molecular Imag-
er® System (Bio-Rad) by calculating the relative amount of the 14-mer
oligonucleotide product with the unreacted 26-mer substrate (product/
product  substrate). The data are expressed as machine counts/ng of
protein.
DNA Base Excision Repair Assay
BER capacity was determined as described previously (17). Briefly,
end-labeled and purified 30-bp oligonucleotides (upper strand, 5-ATA-
TACCGCGGUCGGCCGATCAAGCTTATT-3; lower strand, 3-TATAT-
GGCGCCGGCCGGCTAGTTCGAATAA-5) containing a G:U mismatch
and an HpaII restriction site (GGCC) and protected by a 3 amino
spacer were incubated in a reaction mixture (100 mM Tris-HCl, pH 7.5,
5 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, 2 mM ATP, 0.5 mM NAD, 20 M
dNTPs, 5 mM di-Tris-phosphocreatine, 10 units of creatine phosphoki-
nase) with 50 g of nuclear extract isolated from liver of control and
folate-deficient mice. The reaction mixtures were incubated for 30 min
at 37 °C, followed by 5 min at 95 °C to stop the reaction. The duplex
oligonucleotides were allowed to reanneal for 1 h at room temperature
and spun down to pellet the denatured proteins. The duplex oligonu-
cleotides present in the supernatant were treated with 20 units of HpaII
(Promega, Madison, WI) for 1 h at 37 °C and separated by electrophore-
sis on a 20% denaturing sequencing gel. Repair activity (presence of a
16-mer band) is visualized and quantified using a Molecular Imager®
System (Bio-Rad) by calculating the ratio of the 16-mer oligonucleotide
product with the 30-mer substrate (product/substrate). The data are
expressed as machine counts/g of protein.
ROPS
The relative number of 3-OH group-containing DNA strand breaks
was quantified using a Klenow(exo) incorporation assay based on the
ability of Klenow to initiate DNA synthesis from a 3-OH (31). DNA was
heat-denatured at 100 °C for 5 min, and 0.25 g of DNA was added to
15 l of a Klenow reaction buffer (0.5 mM dTTP, 0.5 mM dGTP, 0.5 mM
dATP, 0.33 M dCTP, 5 units of Klenow(exo) (New England Biolabs,
Beverly, MA)) with 10 Klenow buffer per the manufacturer’s protocol
(New England Biolabs) and 5 Ci of [-32P]dCTP (3000 Ci/mmol;
PerkinElmer Life Sciences). Reaction mixtures were incubated at 16 °C
for 30 min, and the reaction was stopped with the addition of 25 l of
12.5 mM EDTA, pH 8.0. Samples were spotted (5 l) onto scored and
numbered Whatman DE81 chromatography paper and allowed to air-
dry. The chromatography paper was then washed five times for 5 min
each time in 0.5 M Na2HPO4 (dibasic) to remove unincorporated
[-32P]dCTP and then rinsed twice briefly in water and allowed to
air-dry. Paper was cut and placed into scintillation vials with 2.5 ml of
Scinti Verse mixture (Fisher). Incorporation of [-32P]dCTP was quan-
tified using a Packard scintillation counter.
FIG. 2. Analysis of base excision re-
pair capacity and DNA polymerase 
protein in response to folate defi-
ciency in liver. The experiments were
conducted using crude nuclear extracts as
described under “Experimental Proce-
dures.” A, an autoradiograph of a se-
quencing gel indicating repair activity as
visualized by the appearance of a 16-base
fragment. The relative level of base exci-
sion repair in liver tissue of mice fed the
purified isoenergetic diets containing ei-
ther 2 mg/kg folic acid (folate-adequate)
or 0 mg/kg folic acid (folate-deficient) was
quantified using a Bio-Rad Molecular Im-
ager® System, and the data were normal-
ized based on the amount of protein used
in each reaction. The data are expressed
as machine counts/g of protein. Values
represent a mean  S.E. for data obtained
from at least 10 animals in each group. ,
G:U mismatch oligonucleotide incubated
in the absence of nuclear extract and
treated with HpaII restriction endonucle-
ase. B, samples of Western blot images of
-pol protein in liver of mice fed the fo-
late-adequate or folate-deficient diets are
shown (left panel). As a positive control,
samples of Western blot for 2-nitropro-
pane-treated mice (2-NP; 100 mg/kg body
weight) and untreated mice (con) are
shown (right panel). 2-Nitropropane re-
sults in up-regulation of -pol protein
level. The relative level of the 39-kDa
-pol protein for samples from mice fed a
folate-adequate or folate-deficient diet
was determined by Western blot analysis
using monoclonal antisera developed
against mouse -pol. The bands were de-
tected and quantified using an AlphaIn-
notech ChemiImager™ system. The data
are expressed as the I.D.V. of the band/g
of protein loaded. Values are expressed as
mean  S.E. for data obtained from at
least 10 animals in each group. Filled bar,
2 mg/kg folic acid; open bar, 0 mg/kg folic
acid.
Folate Deficiency Induces Functional BER Deficiency 36507
Statistical Analysis
Statistical significance between means was determined using anal-
ysis of variance followed by Fisher’s least significant difference test
where appropriate (32). A p value less than 0.05 was considered statis-
tically significant.
RESULTS
In an extensive study, we have carefully characterized the
effect of folate deficiency on weight gain/loss and plasma folate
levels in C57BL/6 mice. Throughout the 8-week feeding study,
the animals’ food intake and body weights were monitored
twice weekly. Long term folate deficiency can result in toxicity,
evidenced primarily by weight loss. Importantly, in our studies,
no difference in food intake or weight gain/loss was observed
(Fig. 1A). It is essential to demonstrate that the experimental
diet (0 mg/kg folic acid) resulted in decreased serum folate
levels. As expected, a significant decrease in the level of serum
folate in the folate-deficient mouse was observed. The 0 mg/kg
folic acid group had serum folate levels 93% lower than the
control animals (p  0.001), such that the folate levels of the
deficient animals approached zero (Fig. 1B). The addition of 1%
succinyl sulfathiazole allowed attainment of this severity of
folate deficiency by preventing intestinal production of folates.
Since vitamin B12 can alter one-carbon metabolism through its
participation in the methionine synthase reaction, it was im-
portant to determine whether our results might be confounded
by changes in serum B12 levels. Importantly, no differences
were observed in B12 levels between control and deficient
groups (data not shown). There was no effect of -pol heterozy-
gosity on weight or serum folate levels in response to folate
deficiency (data not shown).
This is the first investigation to directly measure the effect of
folate deficiency on BER capacity. It is the BER pathway that
holds primary responsibility for removing folate-induced dam-
age from DNA. Previously we (24) and others (23, 33, 34) have
shown BER to be DNA damage-inducible. As such, we should
expect BER to be up-regulated in response to the increased
levels of DNA damage that occur in folate deficiency. Surpris-
ingly, we observed no increase in BER activity in response to
folate deficiency (Fig. 2A). Additionally, it has been clearly
FIG. 3. Analysis of p53 protein levels in liver of mice fed a
folate-deficient or -adequate diet. Samples of images of Western
blots of p53 protein levels in liver of mice fed the purified isoenergetic
diets containing either 2 mg/kg folic acid (folate-adequate) or 0 mg/kg
folic acid (folate-deficient) are shown. Crude nuclear extracts were
isolated from liver tissues of mice, and the levels of p53 protein in 50 g
of nuclear extract were determined by Western blot analysis using an
ECL detection kit. The relative level of p53 protein was determined by
Western blot analysis using antisera developed against mouse p53. The
bands were detected and quantified using an AlphaInnotech ChemiIm-
ager™ system. The data are expressed as the I.D.V. of the band/g of
protein loaded. Values are expressed as mean  S.E. for data obtained
from at least 10 animals in each group. *, value significantly different
from mice fed the folate-supplemented diet at p  0.01. Filled bar, 2
mg/kg folic acid; open bar, 0 mg/kg folic acid.
FIG. 4. Analysis of UDG activity and protein levels in liver of
mice fed a folate-deficient or -adequate diet. The experiments
were conducted using crude nuclear extracts as described under “Ex-
perimental Procedures.” A, an autoradiograph of a sequencing gel in-
dicating UDG enzymatic activity as visualized by the appearance of a
12-base fragment. The ability of UDG to excise uracil was analyzed
using a 32P-end-labeled 30-mer single strand uracil-containing DNA
substrate (2.5 pmol) incubated with 5 g of crude nuclear extract from
liver of mice fed the folate-adequate or folate-deficient diets. UDG
activity (presence of an 11-base fragment) was visualized and quanti-
fied using a Molecular Imager® System by calculating the relative
amount of the 11-base product with the 30-base substrate (product/
(product  substrate)). The data are expressed as machine counts/g of
protein. All values represent an average  S.E. for data obtained from
at least 10 animals in each group. N, negative control, reaction con-
tained no protein; UGI, the addition of UDG inhibitor to reaction; *,
value significantly different from mice fed the folate supplemented diet
at p  0.05. B, samples of images of Western blots of UDG protein levels
in liver of mice fed the folate-adequate or folate-deficient diets are
shown. The relative level of the UDG protein was determined by West-
ern blot analysis using antiserum developed against mouse UDG. The
bands were detected and quantified using an AlphaInnotech Chemi-
Imager™ system. The data are expressed as the I.D.V. of the band/g of
protein loaded. Values are expressed as mean  S.E. for data obtained
from at least 10 animals in each group. *, value significantly different
from mice fed the folate-supplemented diet at p  0.01. Filled bar, 2
mg/kg folic acid; open bar, 0 mg/kg folic acid.
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determined that -pol levels are rate-determining in BER (16).
In agreement, we show that the lack of inducibility of BER in
response to folate deficiency is preceded by a lack of induction
in -pol (Fig. 2B). Again, this is surprising, since we expected to
see an induction in -pol in response to the stress of folate
deficiency.
In culture, folate deficiency has been shown to increase p53
levels (35, 36) and arrest cells in S-phase (37, 38), ostensibly as
a result of the imbalance in nucleotide precursors that occurs
when folate is limiting. In contrast, in response to folate defi-
ciency in vivo, we observe a 20% reduction in nuclear p53 levels
(Fig. 3, p  0.01). Whereas this contradicts cell culture data, it
is in agreement with gene profiling data from Crott et al. (39),
who demonstrate a reduction in p53 transcription in colonic
mucosa from adult animals in response to folate deficiency.
Although BER can proceed in the absence of p53, a role for p53
in regulating BER has been described (40, 41). Whether the
observed decline in p53 in response to folate deficiency is re-
lated to the inability to induce BER remains to be determined.
The lack of induction in BER activity in response to folate
deficiency supports the hypothesis that folate deficiency results
in an inability to repair DNA damage. It is important to make
a distinction between BER activity and activity of enzymes
within this pathway. Individual enzymes within the pathway
may be altered without changing the overall balance of the
entire pathway and could potentially explain the accumulation
of intermediate DNA repair products. To investigate whether
imbalance within BER occurs in response to folate deficiency,
we assessed the protein levels and enzyme activities of key
proteins within this pathway. As discussed above, it is clear
that folate deficiency does not up-regulate the ability to com-
pletely repair DNA damage, an effect exerted at the level of
-pol expression. This lack of BER induction in response to
folate deficiency has caused us to evaluate this question with
respect to uracil removal.
Synthesis of thymidylate is altered in response to folate
deficiency, resulting in an accumulation of dUMP in nucleotide
pools (6). As a result, uracil becomes misincorporated into
DNA. In response, a specific and efficient enzyme, UDG, cata-
lyzes the removal of uracil from DNA. This represents the first
step in the BER pathway for removal of uracil. In response to
folate deficiency, we observed a 31% increase in UDG activity
(Fig. 4A, p  0.05). This corresponds to a 30% increase in
nuclear UDG protein levels in response to folate deficiency
(Fig. 4B, p  0.01). The increased UDG response to folate
deficiency without a subsequent increase in BER and -pol
represents a dysregulation in coordination of BER that could
result in the detrimental accumulation of genotoxic DNA repair
intermediates.
Following UDG-initiated removal of uracil, a transient aba-
sic site was created. This site was cut by an endonuclease to
generate the 3-OH required for repair synthesis. The endonu-
clease responsible for this incision of the DNA is believed to be
Ape. In response to folate deficiency, we observed no effect on
either Ape protein levels (Fig. 5A) or Ape endonuclease activity
(Fig. 5B). It is presently unclear whether the lack of induction
in Ape protein and activity is physiologically relevant. Both
protein levels and enzymatic activity have been shown to be
DNA damage-inducible (42). However, Ape is not rate-limiting
in BER and may even be dispensable for BER (43). As such, the
impact that its lack of induction will have is questionable.
As discussed above, the removal of uracil by UDG creates a
transient abasic site that must be further processed in order for
repair synthesis to occur. When repair is initiated but not
completed, intermediate repair products can be expected to
accumulate. The type of intermediate that accumulates can
indicate where BER has stalled. Since neither Ape nor -pol is
induced in response to folate deficiency, we might expect to see
an accumulation of abasic sites, an accumulation of single
FIG. 5. Effect of dietary folate on Ape enzymatic activity and
Ape protein levels. The experiments were conducted using crude
nuclear extracts as described under “Experimental Procedures.” A, an
autoradiograph of a sequencing gel indicating Ape endonuclease activ-
ity as visualized by the appearance of a 14-base fragment. The 5-
endonuclease activity of Ape was analyzed using a 32P-end-labeled
26-mer duplex AP-DNA substrate (2.5 pmol) incubated with 100 ng of
crude nuclear extract from liver of mice fed the folate-adequate or
folate-deficient diets. Endonuclease activity (presence of a 14-base frag-
ment) was visualized and quantified using a Molecular Imager® system
by calculating the relative amount of the 14-base product with the
unreacted 26-base substrate (product/(product  substrate)). The data
are expressed as machine counts/ng of protein. All values represent an
average  S.E. for data obtained from at least 10 animals in each group.
B, samples of images of Western blots of Ape protein levels in liver of
mice fed the folate-adequate or folate-deficient diets are shown. The
relative level of the 37-kDa Ape protein was determined by Western blot
analysis using monoclonal antisera developed against mouse Ape. The
bands were detected and quantified using an AlphaInnotech ChemiIm-
ager™ system. The data are expressed as the I.D.V. of the band per g
of protein loaded. Values are expressed as mean  S.E. for data ob-
tained from at least 10 animals in each group. Filled bar, 2 mg/kg folic
acid; open bar, 0 mg/kg folic acid.
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strand breaks, or a combination of both. In response to folate
deficiency, we observe no increase in the level of abasic sites
(Fig. 6A). The lack of accumulation of abasic sites demonstrates
that Ape activity is adequate to process the abasic site and, in
the process, generate a single strand break.
Single strand breaks have been previously shown to accu-
mulate in response to folate deficiency (9, 10, 15, 18, 19). We
have verified that our folate-deficient feeding has likewise re-
sulted in the accumulation of single strand breaks using the
ROPS assay developed by the James laboratory (31). In re-
sponse to folate deficiency, we observed a 37% increase in the
level of single strand breaks (Fig. 6B, p  0.05). In BER, the
strand break created during repair persists until the rate-
limiting step performed by -pol is completed, at which point
ligation can occur. We suggest that these strand breaks arise as
a function of efficient removal of uracil and persist due to
inadequate -pol activity.
In support of this mechanism of strand break accumulation,
we observed an even greater increase in strand breaks in
-pol-haploinsufficient mice that are folate-deficient. In wild
type mice, folate deficiency induced a 37% increase in DNA
strand breaks (Fig. 6B), and this increased to 52% in the
-pol-haploinsufficient mice (Fig. 7). However, no significant
increase in ADLs was observed in wild type mice in response to
folate deficiency, whereas a 38% increase was observed (Fig. 8;
p  0.01) in the -pol-haploinsufficient mice. This is the first
experimental observation of an increased level of ADLs in vivo
and demonstrates that haploinsufficiency in -pol reduces the
efficiency by which these lesions are processed.
DISCUSSION
This study represents the first direct investigation into the
effect of folate deficiency on the capacity of the BER pathway.
As discussed, experimental evidence strongly suggests a re-
duced ability to repair DNA damage induced by folate defi-
ciency. We demonstrate here that when folate is deficient, BER
is unable to mount an adequate response to process the DNA
damage induced by folate deficiency. This is surprising, since
BER is clearly a DNA damage-inducible pathway (23, 24, 33,
34). Folate deficiency results in nucleotide depletion (6, 44),
and we suggest that this depletion may be affecting the induc-
ibility of -pol. Clearly, DNA polymerases require that deoxyri-
bonucleotides exist in proper balance for optimal functioning.
This inability to induce -pol causes a phenotype of reduced
BER efficiency. This functional BER deficiency ultimately
FIG. 6. Analysis of DNA repair in-
termediates in liver DNA of mice fed
a folate-deficient or -adequate diet. A,
liver DNA was isolated from liver tissue
of mice fed the folate-deficient and folate-
adequate diets using the TEMPO extrac-
tion methodology, and the levels of ADLs
were measured using the ASB assay as
described under “Experimental Proce-
dures.” The data are expressed as the
I.D.V. of the band/g of DNA loaded. Val-
ues represent an average  S.E. for data
obtained from at least 10 animals in each
group. B, liver DNA was isolated using
gravity tip extraction columns, and the
number of single strand (ssDNA) breaks
was measured using the ROPS assay as
described under “Experimental Proce-
dures.” The data are expressed as ma-
chine counts/min (CPM)/g of DNA corre-
sponding to the level of [-32P]dCTP
incorporation as quantified by a Packard
scintillation counter. Values represent an
average  S.E. for data obtained from at
least 10 animals in each group. *, value
significantly different from mice fed the
folate-supplemented diet at p  0.01.
Filled bar, 2 mg/kg folic acid; open bar, 0
mg/kg folic acid.
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causes an accumulation of toxic DNA repair intermediates that
is exacerbated by -pol haploinsufficiency.
Folate deficiency alters the balance and coordination of BER
by stimulating initiation of BER without subsequently stimu-
lating the rate-limiting step in the repair process. Inducibility
of UDG has been previously demonstrated (45, 46), but this is
the first report of UDG induction in response to folate defi-
ciency or any dietary manipulation. Additionally, we demon-
strate a tight correlation between levels of UDG protein and
UDG activity, suggesting that UDG activity is regulated by
levels of UDG protein. The abasic sites generated by acceler-
ated UDG activity are rapidly processed in wild type animals,
as evidenced by our inability to detect an increased level of
abasic sites in response to folate deficiency. However, this rapid
processing of abasic sites is not due to increased levels of Ape
protein or Ape activity, since we observe no effect of folate
deficiency on this enzyme. This is in contrast to data from
Courtemanche et al. (38), who show up-regulation in Apex/Ape
mRNA in response to in vitro folate deprivation. Perhaps dif-
ferences between an in vivo system and a cell culture system
exist, or perhaps the inducibility of Ape observed by Courte-
manche et al. (38) is a response to increased redox require-
ments, which may shuttle Ape to the cytoplasm. We do not
believe that an inability to increase Ape activity in response to
folate deficiency is an important biological mechanism in the
processing of abasic sites, since we have previously demon-
strated that one-half the gene dosage of Ape does not result in
an accumulation of abasic sites (47).
On the other hand, the highly efficient processing of abasic
sites results in an accumulation of substrate for the rate-deter-
mining enzyme in BER, -pol. As a combined result of in-
creased substrate for -pol and lack of induction in -pol, repair
stalls and single strand breaks accumulate. We verify that
folate deficiency results in an accumulation of strand breaks
and that these breaks are specifically 3-OH-containing lesions.
Having previously shown that -pol is directly responsible for
the accumulation of strand breaks in response to oxidative
damage (24), the lack of an adequate -pol response is the
likely explanation for the accumulation of strand breaks when
folate is deficient. Strongly in support of the role for -pol in
preventing the resolution of these strand breaks is the in-
creased accumulation of repair intermediates in response to
folate deficiency when -pol is haploinsufficient.
To address whether an underlying BER deficiency would
exacerbate the effects of folate deficiency, we subjected -pol-
haploinsufficient mice to folate deficiency. The lack of induc-
ibility of -pol and BER in response to folate deficiency in
combination with a 50% reduced BER capacity results in an
increased accumulation of DNA strand breaks as well as an
increase in ADLs. This is the first in vivo demonstration of an
increased persistence of these aldehydic groups and requires
some discussion. These ADLs could represent intact abasic
sites resulting from base removal in the absence of subsequent
endonuclease activity. However, this seems unlikely, since
Ape1 activity is neither rate-determining nor affected by folate
deficiency. Furthermore, abasic sites are very efficiently pro-
cessed, making their detection nearly impossible. We propose a
mechanism whereby deficiency in -pol causes both strand
breaks and aldehydic lesions to accumulate as part of the same
lesion, directly as a result of -pol insufficiency. The proposed
mechanism is consistent with previous observations that repair
of abasic sites is 7-fold faster than repair of uracil, which is
4-fold faster than the repair of 8OHdG (48).
In the haploinsufficient mouse, both 3-OH groups and free
aldehyde groups accumulate. Fig. 9A demonstrates how the
removal of uracil by UDG creates a transient intact abasic site
that is processed by Ape1 such that both an aldehyde group
detectable by the aldehyde reactive probe and a 3-OH group
detectable by Klenow incorporation are present. We suggest
that in the -pol-haploinsufficient mouse, this 3-OH/aldehydic
lesion persists, directly as a result of the reduced ability to
insert a new nucleotide, excise the deoxyribose flap, and com-
plete repair. In a model with adequate levels of -pol, this
3-OH/aldehydic lesion should not persist, and in fact, it does
not. The wild type mice subjected to folate deficiency accumu-
late only the 3-OH lesions in the absence of the aldehydic
lesions. Our hypothesis that folate deficiency exerts its effects
FIG. 7. Analysis of DNA single strand breaks in liver DNA of
-pol/ mice fed a folate-adequate diet and -pol/ mice fed a
folate-deficient diet. Liver DNA was isolated using gravity tip ex-
traction columns, and the number of single strand (ssDNA) breaks was
measured using the ROPS assay as described under “Experimental
Procedures.” The data are expressed as machine counts/min (CPM)/g
of DNA, corresponding to the level of [-32P]dCTP incorporation as
quantified by a Packard scintillation counter. Values represent an
average  S.E. for data obtained from at least 10 animals in each group.
*, value significantly different from mice fed the folate-supplemented
diet at p  0.01. Filled bar, -pol/ mice fed 2 mg/kg folic acid; open
bar, -pol/ mice fed 0 mg/kg folic acid.
FIG. 8. Analysis of aldehydic DNA lesions in liver DNA of
-pol/ mice fed a folate-adequate diet and -pol/ mice fed a
folate-deficient diet. Liver DNA was isolated from liver tissue of mice
fed the folate-deficient and folate-adequate diets using the TEMPO
extraction methodology, and the levels of ADLs were measured using
the ASB assay as described under “Experimental Procedures.” The data
are expressed as the I.D.V. of the band/g of DNA loaded. Values
represent an average  S.E. for data obtained from at least 10 animals
in each group. *, value significantly different from mice fed the folate-
supplemented diet at p  0.01. Filled bar, -pol/ mice fed 2 mg/kg
folic acid; open bar, -pol/ mice fed 0 mg/kg folic acid.
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by altering regulation of -pol seems faulty if different classes
of lesions arise in the -pol model as compared with the wild
type model in response to folate deficiency. This is addressed in
Fig. 9B, which depicts the mechanism by which 3-OH groups
can accumulate without a corresponding accumulation in alde-
hyde groups. In this case, the first step of repair involves
removal of the damaged base by a bifunctional glycosylase,
generating a strand break that does not contain a 3-OH group
but does contain an aldehyde group. This is not a lesion we
have been able to detect. The second step is the trimming of the
3-phosphoglycolate, which removes the aldehyde group and
generates a 3-OH group. This is consistent with the lesions we
have been able to detect in response to folate deficiency in wild
type animals. These data support previous data (48) demon-
strating a preference for the repair of abasic sites and uracil
over the repair of oxidized bases, like 8OHdG. Oxidized bases
can be expected to arise both as a result of cellular metabolism
and as a result of increased homocysteine levels in response to
folate deficiency. As such, we propose that in wild type animals
both uracil and oxidized bases are being processed, but shut-
tling toward repair of uracil prevents the accumulation of ura-
cil-initiated repair intermediates while forcing the accumula-
tion of repair intermediates arising from bifunctional
glycosylases. However, in the face of -pol haploinsufficiency,
-pol levels fall to a critically low level such that all of the
repair intermediates begin to accumulate.
When the amount of -pol is limiting, as it is in the -pol-
haploinsufficient mouse and as we now know it is in folate
deficiency, BER is thrown out of balance, and toxic repair
intermediates accumulate. This accumulation of repair inter-
mediates is critically dependent on glycosylase-mediated re-
moval of the damaged base, and we suggest that the up-regu-
lation in UDG activity is a critical factor in the phenotype
resulting from folate deficiency. This is supported by the ability
of an UNG1 deletion to rescue apn1/apn2/rad1 lethality (49).
The inability of folate deficiency to induce BER results in a
functional BER deficiency. Having previously established that
BER deficiency in the -pol-haploinsufficient mouse predis-
poses to cancer, we suggest that the functional BER deficiency
induced by folate deficiency will likewise predispose to cancer,
primarily by reducing DNA damage tolerance. We have clearly
shown that reduced BER capacity in response to -pol haplo-
insufficiency (17) and in response to aging (50) reduces the
threshold of DNA damage tolerance. Folate deficiency likewise
reduces tolerance to DNA damage (7–11), further support that
BER deficiency is responsible for the phenotype expressed by
folate deficiency. Additionally, a genetic defect in -pol inten-
sifies the effects of folate deficiency, demonstrating that -pol
haploinsufficiency and folate deficiency interact to increase
cancer risk. Future investigations should focus on identifying
important cis-acting (e.g. promoter methylation) and trans-
acting factors important in regulating -pol in response to
FIG. 9. Processing of uracil and 8OHdG lesions by monofunctional UDG (A) and bifunctional DNA glycosylase (OGG1) (B) and Ape
is shown. The solid arrows and open arrow point to aldehydic DNA lesions and DNA 3-OH, respectively.
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folate deficiency. Presently, these data provide evidence that
gene/nutrient as well as nutrient/environment interactions ex-
ist that predispose to cancer and that in both cases regulation
of DNA polymerase  is a critical factor.
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